The timeline does not support this mechanism
PLoS One 13, e0191353
Introducing alcohol undermines that precision, but starting with a low-quality product and then adding alcohol would be exponentially worse, creating a completely unpredictable and potentially unsafe scenario.
Quick Answer: Melanotan II for sleep isn't a primary application, but drowsiness is a commonly reported side effect in 20-40% of users
Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality in patients with type 2 diabetes: a systematic review and meta-analysis
So here were taking a system, the incretin system, GLP-1 or GIP, or coming soon glucagon, and were boosting it in people who have regular levels